Le Lézard
Classified in: Health
Subjects: WOM, CFG, MIN, DEI

Removing barriers for sperm and ova donors


OTTAWA, ON, May 8, 2024 /CNW/ - Many people including those experiencing infertility, single parents and same-sex couples, may choose assisted human reproduction, including the use of donated sperm and ova, as a way of growing their families.

Today, the Honourable Mark Holland, Minister of Health, is announcing that Health Canada's updated screening criteria for sperm and ova donors have come into force, integrating the latest scientific evidence and input from consultations with subject-matter experts in donor screening, industry, patient associations, and 2SLGBTQIA+ groups.

In 2022, Health Canada approved submissions from Canada's two blood operators, Canadian Blood Services and Héma-Québec, to eliminate the blood donor deferral period for men who have sex with men (MSM) and other individuals affected by the previous deferral policies. Today's announcement builds on that progress and is a step forward in reducing barriers that prevented many individuals from donating sperm. The Government of Canada is committed to ensuring that its sperm and ova donation policy is safe, inclusive and scientifically based.

Health Canada is working with the Canadian Standards Association to discuss potential changes to the MSM donor screening criteria for cells, tissues and organs (CTOs), that are under current consideration by experts in the field of CTO donation. The Government of Canada is working toward a more inclusive donation system that is supported by the recent advancements in scientific evidence.

Quotes

"Our government is committed to continuing safe, inclusive, and scientifically-based sperm and ova donation policies. By following the latest evidence and science, we are ensuring that the sperm and ova supply is stable to allow all Canadians to grow their families."

The Honourable Mark Holland 
Minister of Health

Associated Links

SOURCE Health Canada (HC)


These press releases may also interest you

at 02:30
New Research by Tea Advisory Panel Reveals That Three Quarters Of Brits Never Drink Tea Before A Workout Despite It Counting Towards Fluid Intake Recommendations
Ahead of International Tea Day - 21st May 2024  - and with summer inspiring more of us to get off the sofa to be active, a 2024 real-world research study1 reviewed by the tea science experts at the Tea Advisory Panel ? www.teaadvisorypanel.com -...

at 02:30
TREEFROG PRESENTS DATA FROM THEIR PARKINSON'S DISEASE CELL THERAPY PROGRAM AT THE 29TH WORLD CONGRESS ON PARKINSON'S DISEASE AND RELATED DISORDERS (IAPRD) IN LISBON
TreeFrog Therapeutics will participate for the first time at the IAPRD, to present data from their Parkinson's disease cell therapy program, which has demonstrated excellent results with full motor recovery at 16 weeks in preclinical studies.[1]...

at 02:20
Vicore Announces Positive Final Results from the Phase 2a AIR Trial Demonstrating Buloxibutid Improves Lung Function Over 36 Weeks in Patients with Idiopathic Pulmonary Fibrosis
Vicore Pharma Holding (STO:VICO)Buloxibutid improved lung function-measured by FVC-by over 200 mL from baseline at 36 weeks of treatment.The therapy was safe and well tolerated with no treatment-related serious adverse events.Biomarker analysis...

at 02:07
GC Biopharma/Novel Pharma's Sanfilippo Syndrome Treatment Obtains FDA IND Approval
GC Biopharma (006280. KS) and Novel Pharma announced that its jointly developed MPS IIIA 'GC1130A' treatment has received FDA IND approval....

at 02:05
PureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary Share
PureTech Health plc ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today announces the opening of its proposed $100 million tender offer (the "Tender...

at 01:30
Urinary Catheters Market size is set to grow by USD 2.44 bn from 2024-2028, rising geriatric population with urinary incontinence to boost the market growth, Technavio
The global urinary catheters market  size is estimated to grow by USD 2.44 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 7.63%  during the forecast period. ...

More news about Health...


News published on and distributed by: